Correction of publication from April 10, 2013 - Carl Zeiss Meditec AG : Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act) with the aim of pan-European distribution

April 11, 2013 Carl Zeiss Meditec AG / Correction of publication from April 10, 2013 - Carl Zeiss Meditec AG : Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act) with the aim of pan-European distribution . Processed and transmitted by Thomson Reuters ONE. The issuer is solely responsible for the content of this announcement. Pursuant to Art. 21 (1) Sentence 1, Art. 22 (1) and Art. 24 WpHG, Noerr LLP, Munich, Germany, informed Carl Zeiss Meditec AG, Jena, Germany, on 09 April 2013, on behalf of its client, Massachusetts Mutual Life Insurance Company, in accordance with Art. 21 (1), 22 (1) and 24 (1) on the following changes in voting rights: On 04 April 2013, the share of voting rights of Oppenheimer Acquisition Corp. 6803 S. Tuscon Way, Centennial, CO, United States of America, 80112-3924, in Carl Zeiss Meditec AG, Jena (ISIN DE0005313704, WKN: 531370) fell below the threshold of 3%. On 04 April 2013 the percentage of voting rights of Oppenheimer Acquisition Corp. amounted to 2.98% (corresponding to 2,422,279 shares of a total of 81,309,610 shares) - rounded on two right-of-comma positions - pursuant to Art. 22 (1) Sentence 1 No. 6 Sentence 2 WpHG. Of this percentage of Oppenheimer Acquisition Corp., 0.62% is allocated to the Oppenheimer International Small Company Fund and 2.36% to the Oppenheimer Global Opportunities Fund to Oppenheimer Funds, Inc. Jena, April 2013 Carl Zeiss Meditec AG The Management Board Carl Zeiss Meditec AG Goeschwitzer Strasse 51-52 07745 Jena, Germany This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that: (i) the releases contained herein are protected by copyright and other applicable laws; and (ii) they are solely responsible for the content, accuracy and originality of the information contained therein. Source: Carl Zeiss Meditec AG via Thomson Reuters ONE [HUG#1692333]